Akoya Biosciences, Inc. (NASDAQ:AKYA) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET
Company Participants
Priyam Shah - Head of Investor Relations
Brian McKelligon - Chief Executive Officer
Johnny Ek - Chief Financial Officer
Conference Call Participants
Kyle Mikson - Canaccord Genuity
Lucas Baranowski - UBS
Rachel Vatnsdal - JPMorgan Chase
Mark Massaro - BTIG
Edmund Tu - Morgan Stanley
Tim Chiang - Capital One
David Westenberg - Piper Sandler
Mason Carrico - Stephens Inc.
Operator
Good day and welcome to the Akoya Biosciences Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. As a reminder, this call is being recorded.
I would now like to turn the call over to Priyam Shah, Head of Investor Relations at Akoya Biosciences. You may begin.
Priyam Shah
Thank you, operator and thank you to everyone who’s joining us today on this call. I am Priyam Shah, Head of Investor Relations at Akoya Biosciences.
On the call today, we have Brian McKelligon, Chief Executive Officer; and Johnny Ek, our Chief Financial Officer. Earlier today, Akoya released financial results for the second quarter ended June 30, 2023. A copy of the press release is available on the company’s website.
Before we begin, I’d like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements.
Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with Akoya’s business, please refer to the risks identified in our filings with the US Securities and Exchange Commission, including in the Risk Factors section of our annual report on Form 10-K for the year ended December 31, 2022, filed on March 6, 2023, and subsequent filings with the SEC, including our quarterly report on Form 10-Q for the second quarter ended June 30, 2023, filed today, August 7, 2023.
We urge you to consider these factors and you should be aware that these statements are considered estimates only and are not a guarantee of future performance. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, August 7, 2023.